Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · IEX Real-Time Price · USD
82.40
+1.57 (1.94%)
May 14, 2024, 4:00 PM EDT - Market closed
1.94%
Market Cap 4.79B
Revenue (ttm) 1.28B
Net Income (ttm) 101.95M
Shares Out 58.11M
EPS (ttm) 1.75
PE Ratio 47.09
Forward PE 23.83
Dividend n/a
Ex-Dividend Date n/a
Volume 270,432
Open 81.83
Previous Close 80.83
Day's Range 81.02 - 82.62
52-Week Range 62.58 - 85.62
Beta 0.91
Analysts Buy
Price Target 89.44 (+8.54%)
Earnings Date Apr 30, 2024

About MMSI

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bo... [Read more]

Sector Healthcare
IPO Date Aug 9, 1990
Employees 6,950
Stock Exchange NASDAQ
Ticker Symbol MMSI
Full Company Profile

Financial Performance

In 2023, MMSI's revenue was $1.26 billion, an increase of 9.24% compared to the previous year's $1.15 billion. Earnings were $94.41 million, an increase of 26.70%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is $89.44, which is an increase of 8.54% from the latest price.

Price Target
$89.44
(8.54% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe

SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced US Food and Drug Administration (FDA) 510(k) ...

21 hours ago - GlobeNewsWire

Merit Medical Reports Results for First Quarter Ended March 31, 2024

* Constant currency revenue; constant currency revenue, organic; non-GAAP gross profit and margin; non-GAAP operating income and margin; non-GAAP net income; non-GAAP EPS; and free cash flow are non-G...

14 days ago - GlobeNewsWire

Merit Medical Launches the Micro ACE™ Advanced Micro-Access System

Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases Micro ACE combines a unique balance of stiffness and resiliency to achieve succe...

2 months ago - GlobeNewsWire

Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024

SOUTH JORDAN, Utah, March 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rel...

2 months ago - GlobeNewsWire

Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting

Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320 Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320

2 months ago - GlobeNewsWire

Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026

SOUTH JORDAN, Utah, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today introduced its Continued Gr...

2 months ago - GlobeNewsWire

Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance

*  Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-...

2 months ago - GlobeNewsWire

Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System

New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise excision and successful surgeries New guidance system marks signifi...

3 months ago - GlobeNewsWire

First Patient Enrolled in Merit Medical's MOTION Study

SOUTH JORDAN, Utah, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the successful en...

4 months ago - GlobeNewsWire

Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 2024

*  Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP ...

4 months ago - GlobeNewsWire

Merit Medical Announces Process for Chief Executive Officer Succession Planning

SOUTH JORDAN, Utah, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today outlined the ongoing succes...

5 months ago - GlobeNewsWire

Merit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029

SOUTH JORDAN, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq: MMSI) (“Merit”), a leading global manufacturer and marketer of healthcare technology, announced the pricing o...

5 months ago - GlobeNewsWire

Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes

SOUTH JORDAN, Utah, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq: MMSI) (“Merit”), a leading global manufacturer and marketer of healthcare technology, announced today that it...

5 months ago - GlobeNewsWire

Merit Medical Reports Results for Third Quarter Ended September 30, 2023

*  Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-...

7 months ago - GlobeNewsWire

Merit Medical Launches Expanded Maestro® Microcatheter Line

New multipurpose microcatheter length complements Merit's radial-first legacy New multipurpose microcatheter length complements Merit's radial-first legacy

7 months ago - GlobeNewsWire

Merit Medical Systems to Announce Third Quarter 2023 Results on October 26, 2023

SOUTH JORDAN, Utah, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...

7 months ago - GlobeNewsWire

Merit Medical Launches the Aspira® Evacuated Drainage Bottle

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients Advanced design complements comprehensive drainage portfolio, expanding...

8 months ago - GlobeNewsWire

Merit Medical's WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of...

10 months ago - GlobeNewsWire

Merit Medical Reports Results For Second Quarter June 30, 2023

*  Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-...

10 months ago - GlobeNewsWire

Merit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023

SOUTH JORDAN, Utah, July 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...

11 months ago - GlobeNewsWire

Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.

SOUTH JORDAN, Utah, June 08, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced it has completed ...

1 year ago - GlobeNewsWire

Merit Medical Announces New Five-Year Senior Secured Credit Agreement

Credit agreement includes a revolving credit facility of up to $700 million and a term loan facility of up to $150 million Credit agreement includes a revolving credit facility of up to $700 million a...

1 year ago - GlobeNewsWire

Merit Medical Reports Results for First Quarter March 31, 2023

Q1 2023 reported revenue of $297.6 million, up 8.0% compared to Q1 2022 Q1 2023 constant currency revenue, organic* up 9.8% compared to Q1 2022 Q1 2023 GAAP operating margin of 8.9%, compared to 5.5% ...

1 year ago - GlobeNewsWire

Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023

SOUTH JORDAN, Utah, April 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rel...

1 year ago - GlobeNewsWire

Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering

New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products New sizes of advanced articulating microcatheter enhance a market-leading portfolio of v...

1 year ago - GlobeNewsWire